Back to Search
Start Over
Photodynamic Therapy of Inorganic Complexes for the Treatment of Cancer †
- Source :
- Photochemistry and Photobiology. 98:17-41
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
-
Abstract
- Photodynamic therapy (PDT) is a medicinal tool that uses a photosensitiser and a light source to treat several conditions, including cancer. PDT uses reactive oxygen species (ROS) such as cytotoxic singlet oxygen (1 O2 ) to induce cell death in cancer cells. Chemotherapy has historically utilized the cytotoxic effects of many metals, especially transition-metal complexes. However, chemotherapy is a systemic treatment so all cells in a patient's body are exposed to the same cytotoxic effects. Transition metal complexes have also shown high cytotoxicity as PDT agents. PDT is a potential localized method for treating several cancer types by using inorganic complexes as photosensitizing agents. This review covers several in vitro and in vivo studies, as well as clinical trials that reported on the anti-cancer properties of inorganic pharmaceuticals used in PDT against different types of cancer.
- Subjects :
- Chemotherapy
Photosensitizing Agents
Singlet Oxygen
Chemistry
Singlet oxygen
medicine.medical_treatment
Cancer
Antineoplastic Agents
Photodynamic therapy
General Medicine
Photosensitizing Agent
medicine.disease
Biochemistry
chemistry.chemical_compound
Photochemotherapy
Coordination Complexes
In vivo
Neoplasms
Cancer cell
medicine
Cancer research
Humans
Physical and Theoretical Chemistry
Cytotoxicity
Subjects
Details
- ISSN :
- 17511097 and 00318655
- Volume :
- 98
- Database :
- OpenAIRE
- Journal :
- Photochemistry and Photobiology
- Accession number :
- edsair.doi.dedup.....80258b66ca4a0f4c8938eba6260884b2
- Full Text :
- https://doi.org/10.1111/php.13467